A Phase 2 Study to Assess the Safety of EI-1071 and the Effects of EI-1071 on Neuroinflammation in Alzheimer's Disease Patients
Elixiron Immunotherapeutics (Hong Kong) Ltd.
Elixiron Immunotherapeutics (Hong Kong) Ltd.
Wake Forest University Health Sciences
Mayo Clinic
UNC Lineberger Comprehensive Cancer Center
Massachusetts General Hospital
Helse Stavanger HF
Region Stockholm
Inmune Bio, Inc.
University of Rochester
Sutter Health
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
UNC Lineberger Comprehensive Cancer Center
CHU de Quebec-Universite Laval
National University of Singapore
Peking Union Medical College Hospital
University of Illinois at Urbana-Champaign
Vanderbilt University Medical Center
National University of Singapore